Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01312376
First received: March 9, 2011
Last updated: July 18, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)